Boston Children’s Hospital announced today that it partnered with ElevateBio for a five-year cell and gene therapy advancement program.
The collaborative agreement will seek to advance cell and gene therapy programs originating out of Boston Children’s Hospital with an introduction to Boston Children’s translational research capabilities.
Get the full story at our sister site, Drug Delivery Business News.
Filed Under: Drug Delivery, Drug Discovery, Drug Discovery and Development, Immunology, Oncology
Tell Us What You Think!
You must be logged in to post a comment.